Literature DB >> 33584291

MicroRNAs and Natural Compounds Mediated Regulation of TGF Signaling in Prostate Cancer.

Zeeshan Javed1, Khushbukhat Khan2, Amna Rasheed3, Haleema Sadia4, Shahid Raza1, Bahare Salehi5, William C Cho6, Javad Sharifi-Rad7,8, Wojciech Koch9, Wirginia Kukula-Koch10, Anna Głowniak-Lipa11, Paweł Helon12.   

Abstract

Prostate cancer (PCa) is with rising incidence in male population globally. It is a complex anomaly orchestrated by a plethora of cellular processes. Transforming growth factor-beta (TGF-β) signaling is one of the key signaling pathways involved in the tumorigenesis of PCa. TGF-β signaling has a dual role in the PCa, making it difficult to find a suitable therapeutic option. MicroRNAs (miRNAs) mediated regulation of TGF-β signaling is responsible for the TGF-ß paradox. These are small molecules that modulate the expression of target genes and regulate cancer progression. Thus, miRNAs interaction with different signaling cascades is of great attention for devising new diagnostic and therapeutic options for PCa. Natural compounds have been extensively studied due to their high efficacy and low cytotoxicity. Here, we discuss the involvement of TGF-ß signaling in PCa with the interplay between miRNAs and TGF-β signaling and also review the role of natural compounds for the development of new therapeutics for PCa.
Copyright © 2021 Javed, Khan, Rasheed, Sadia, Raza, Salehi, Cho, Sharifi-Rad, Koch, Kukula‐Koch, Głowniak‐Lipa and Helon.

Entities:  

Keywords:  biomarkers; miRNAs; natural compounds; prostate cancer; therapeutics; transforming growth factor-beta signaling

Year:  2021        PMID: 33584291      PMCID: PMC7873640          DOI: 10.3389/fphar.2020.613464

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  126 in total

1.  Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.

Authors:  Shuai Hu; Wei Yu; Tian-Jing Lv; Chawn-Shang Chang; Xin Li; Jie Jin
Journal:  Mol Membr Biol       Date:  2014-03-20       Impact factor: 2.857

2.  Drier Climatic Conditions Increase Withanolide Content of Withania coagulans Enhancing Its Inhibitory Potential Against Human Prostate Cancer Cells.

Authors:  Samiya Rehman; Ken Keefover-Ring; Ihsan Ul Haq; Erum Dilshad; Mohammad Imran Khan; Nosheen Akhtar; Bushra Mirza
Journal:  Appl Biochem Biotechnol       Date:  2018-12-10       Impact factor: 2.926

3.  Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro.

Authors:  Jillian N Eskra; Alaina Dodge; Michael J Schlicht; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2019-08-12       Impact factor: 2.900

4.  Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells.

Authors:  Mingfang Ao; Karin Williams; Neil A Bhowmick; Simon W Hayward
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

5.  MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2.

Authors:  C Zhiping; T Shijun; W Linhui; W Yapei; Q Lianxi; D Qiang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-11       Impact factor: 3.507

6.  Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.

Authors:  Nosheen Akhtar; Deeba N Syed; Rahul K Lall; Bushra Mirza; Hasan Mukhtar
Journal:  Mol Carcinog       Date:  2018-02-27       Impact factor: 4.784

7.  Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer.

Authors:  Xiaojuan Li; Jun Li; Yi Cai; Shubin Peng; Jun Wang; Zhaoming Xiao; Yu Wang; Yiran Tao; Jun Li; Qu Leng; Dinglan Wu; Shaodong Yang; Ziliang Ji; Yuefu Han; Liren Li; Xin Gao; Chunxian Zeng; Xingqiao Wen
Journal:  Cancer Lett       Date:  2018-01-10       Impact factor: 8.679

8.  Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells.

Authors:  Asuman Deveci Ozkan; Suleyman Kaleli; Hacer Ilke Onen; Mehmet Sarihan; Gamze Guney Eskiler; Aysel Kalayci Yigin; Mehmet Akdogan
Journal:  Immunopharmacol Immunotoxicol       Date:  2020-02-12       Impact factor: 2.730

9.  Curcumin derivatives as photosensitizers in photodynamic therapy: photophysical properties and in vitro studies with prostate cancer cells.

Authors:  K T Kazantzis; K Koutsonikoli; B Mavroidi; M Zachariadis; P Alexiou; M Pelecanou; K Politopoulos; E Alexandratou; M Sagnou
Journal:  Photochem Photobiol Sci       Date:  2020-02-19       Impact factor: 3.982

10.  Phenethyl isothiocyanate (PEITC) suppresses prostate cancer cell invasion epigenetically through regulating microRNA-194.

Authors:  Chengyue Zhang; Limin Shu; Hyuck Kim; Tin Oo Khor; Renyi Wu; Wenji Li; Ah-Ng Tony Kong
Journal:  Mol Nutr Food Res       Date:  2016-05-17       Impact factor: 5.914

View more
  1 in total

Review 1.  Dietary stilbenes as modulators of specific miRNAs in prostate cancer.

Authors:  Anait S Levenson
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.